Medtronic plc MDT NYSE

Medtronic plc (MDT) reported total assets of $91.68B and total liabilities of $43.42B for fiscal year 2025, resulting in total equity of $48.26B.

The company held $8.97B in cash and short-term investments. Total debt stood at $28.52B, with net debt of $26.3B. The Debt-to-Equity (D/E) ratio was 0.59 (moderate).

Current ratio is 1.85, indicating strong short-term liquidity. Interest coverage is 8.2x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.59, current ratio of 1.85, interest coverage 8.2x — balance sheet is strong
• MOAT (86/100) — Total assets $91.68B and equity $48.26B support the company's competitive scale
• VALUE (47/100) — Debt-to-Equity 0.59 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 69/100 with 3/7 criteria passed.

ABT

Abbott Laboratories

$101.07

+0.38%

SYK

Stryker Corporation

$345.88

-0.39%

GSK

GSK plc

$59.18

+0.41%

BMY

Bristol-Myers Squibb Company

$58.08

+0.03%

SNY

Sanofi

$47.64

+1.45%

VRTX

Vertex Pharmaceuticals Incorporated

$444.28

+0.96%

HCA

HCA Healthcare, Inc.

$498.66

+0.25%

MCK

McKesson Corporation

$862.79

-0.21%